Atlas Trials

MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer

Clinical trial NCT01656551 · UNKNOWN

Trial details

NCT number
NCT01656551
Sponsor
National Cancer Institute, Naples
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
Start date
2012-08-01
Primary completion
2024-11-01
Enrollment
232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.